A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2006
10/18/2006	EP1437358B1 Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
10/18/2006	EP1358332B1 A serpin in bifidobacteria
10/18/2006	EP1337636B1 Soluble zcytor 11 cytokine receptors
10/18/2006	EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006	EP1165778B1 Uses of casb618 polynucleotides and polypeptides
10/18/2006	EP1155119B1 Bhv-1 gene-deleted virus vaccine
10/18/2006	EP1141286B1 Cytokine receptor chain
10/18/2006	EP1107957B1 Pyrimidine compounds
10/18/2006	EP1019500B1 Ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
10/18/2006	EP1003533B1 Use of herpes vectors for tumor therapy
10/18/2006	EP0969862B1 Synthetic hiv gag genes
10/18/2006	EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
10/18/2006	EP0931063B1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
10/18/2006	EP0927252B1 Antibodies against interferon alpha/beta receptor
10/18/2006	CN1849339A 治疗性结合分子 Therapeutic binding molecules
10/18/2006	CN1849318A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/18/2006	CN1849302A 1, 3-disubstituted azetidine derivatives for use as CCR-3 receptor antagonists in the treatment of inflammatory and allergic diseases
10/18/2006	CN1849135A Methods for treating interleukin-6-related diseases
10/18/2006	CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006	CN1847229A Novel compounds
10/18/2006	CN1847226A Quinolyl amide derivative and its prepn process and use
10/18/2006	CN1846786A Vaccins vivants recombines et adjuves
10/18/2006	CN1846746A Chinese medicine ginseng-notopterygium powder for treating rhinitis
10/18/2006	CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006	CN1846716A Functional bifid bacterium microcapsule
10/18/2006	CN1280308C Production of polysaccharide peptide
10/18/2006	CN1280289C Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
10/18/2006	CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006	CN1280267C Sulfonylaminocarboxylic acids
10/18/2006	CN1279976C Adjuvant for transcutaneous immunization
10/18/2006	CN1279975C Inducer of blood vessel neogenesis
10/18/2006	CN1279958C Compound formula preparation eontaining glucocorticoid medicine
10/18/2006	CN1279932C Improved method for preparing 'Zhenqi Fuzheng' medicine
10/18/2006	CN1279904C Vitamin C composition containing sodium vitamin C
10/17/2006	US7122687 Sodium salt formation of Mycophenolic acid
10/17/2006	US7122639 Chemokine alpha-2 antibodies
10/17/2006	US7122638 Hybridomas cell lines; viricides
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122556 Phenylalanine enamide derivatives
10/17/2006	US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006	US7122542 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
10/17/2006	US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006	US7122530 24-hydroxyvitamin D, analogs and uses thereof
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122206 Spraying into nose; triamcinolone acetonide
10/17/2006	US7122197 Compounds from Moraxella catarrhalis
10/17/2006	US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody
10/17/2006	US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
10/17/2006	CA2324919C Hiv inhibiting pyrimidine derivatives
10/17/2006	CA2197207C Hiv protease inhibitor combination
10/17/2006	CA2177179C Antagonists to chaperonin 10
10/15/2006	CA2504279A1 Materials and method of modulating the immune response using t helper-antigen presenting cells
10/12/2006	WO2006108103A1 Purine and imidazopyridine derivatives for immunosuppression
10/12/2006	WO2006107184A1 A pharmaceutical composition for the treatment of atopic dermatitis containing 4-hydroxy-5-methoxy-4-[2-methyl-3-(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro [2,5]octan-6-one
10/12/2006	WO2006107101A1 Process for production of regulatory t cell
10/12/2006	WO2006106959A1 Anti-cd-20 monoclonal antibody
10/12/2006	WO2006106926A1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
10/12/2006	WO2006106839A1 METHOD FOR SCREENING AUXILIARY AGENT CAPABLE OF PROMOTING THE INDUCTION OF INTERFERON-α AND/OR -β (IFN-α/β) EXPRESSION
10/12/2006	WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006	WO2006105811A1 Compounds useful as modulators of the proteasome activity
10/12/2006	WO2006039792A8 Method of treating autoimmune diseases
10/12/2006	US20060230467 Plant deoxyribonucleoside kinase enzymes and their use
10/12/2006	US20060229342 TNF-a production inhibitors
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229324 Quinazolin-4-one derivatives
10/12/2006	US20060229320 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/12/2006	US20060229319 For treatment of allergies; antihistamines
10/12/2006	US20060229315 3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/12/2006	US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
10/12/2006	US20060229236 Cyclic tetrapeptide compound and use thereof
10/12/2006	US20060228752 Genetic polymorphisms in the preprotachykinin gene
10/12/2006	US20060228351 Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor
10/12/2006	US20060228341 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/12/2006	DE19940944B4 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms
10/12/2006	CA2604488A1 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
10/12/2006	CA2604161A1 Purine and imidazopyridine derivatives for immunosuppression
10/12/2006	CA2604133A1 Compounds useful as modulators of the proteasome activity
10/12/2006	CA2603826A1 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
10/12/2006	CA2603347A1 Oil-in-water emulsions of lignans that exhibit improved absorption rate
10/12/2006	CA2603030A1 Benzyloxypropylamine derivative
10/11/2006	EP1710314A1 Humanized immunoglobulin reactive with alpha4beta7 integrin
10/11/2006	EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
10/11/2006	EP1710252A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/11/2006	EP1709995A1 Asthma/allergy therapy using nigella sativa
10/11/2006	EP1709965A2 Methods of treating cytokine mediate diseases
10/11/2006	EP1709080A2 ANTIBODIES TO MAdCAM
10/11/2006	EP1709079A2 Compositions and methods for treating t-cell mediated autoimmune diseases
10/11/2006	EP1709007A1 N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors
10/11/2006	EP1708673A2 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies
10/11/2006	EP1471896B1 Formulations for inhalation
10/11/2006	EP1140149B1 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment

1 ... 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 ... 1172